Robert Schnoll, PhD
Associate Director for Population Science, Abramson Cancer Center Professor and Director, Center for Interdisciplinary Research on Nicotine Addiction, Department of Psychiatry, Perelman School of Medicine
Courses Taught
PUBH 7090 Capstone II
Ask Me About
Scrabble, Running, & Canada
Contact
Brief Bio
I am a tobacco control researcher and implementation scientist. Our work in tobacco control focuses on improving the use and effectiveness of evidence-based tobacco treatments. As an implementation scientist, our work leverages behavioral economics to address practice gaps across a range of clinical settings such as oncology care and genetic testing.
Publications
- Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial
- Cluster Randomized Pragmatic Clinical Trial Testing Behavioral Economic Implementation Strategies to Improve Tobacco Treatment for Patients With Cancer Who Smoke
- The use of biomarkers to guide precision treatment for tobacco use
- Efficacy and safety of combination behavioral activation for smoking cessation and varenicline for treating tobacco dependence among individuals with current or past major depressive disorder: A 2 × 2 factorial, randomized, placebo-controlled trial